Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 223,279 |
|
|||||
| News | - | ||||||
| Day High | 2.51 | Low High |
|||||
| Day Low | 2.35 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cellectis SA | CLLS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0156 | 0.63% | 2.5056 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.51 | 2.35 | 2.51 | 2.5056 | 2.49 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 370 | 223,279 | US$ 2.43 | US$ 543,548 | - | 0.962777 - 3.7735 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:27:55 | formt | 281 | US$ 2.55 | USD |
Cellectis SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 118.76M | 45.68M | - | 27.67M | -106.14M | -2.32 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cellectis News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLLS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.58 | 2.65 | 2.35 | 2.57 | 27,226 | -0.0744 | -2.88% |
| 1 Month | 2.61 | 2.95 | 2.30 | 2.63 | 31,429 | -0.1044 | -4.00% |
| 3 Months | 2.90 | 3.13 | 2.30 | 2.68 | 35,938 | -0.3944 | -13.60% |
| 6 Months | 1.00 | 3.7735 | 0.962777 | 2.75 | 980,370 | 1.51 | 150.56% |
| 1 Year | 1.93 | 3.7735 | 0.962777 | 2.70 | 517,511 | 0.5756 | 29.82% |
| 3 Years | 19.31 | 20.42 | 0.962777 | 4.63 | 287,691 | -16.80 | -87.02% |
| 5 Years | 19.76 | 34.71 | 0.962777 | 9.61 | 254,353 | -17.25 | -87.32% |
Cellectis Description
| Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body's immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company's gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. It reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology. |
